Neutrophils in the premetastatic niche: key functions and therapeutic directions

2024-9-14

Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the “all-around warrior” in immunotherapy

2024-9-14

Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics

2024-9-13

Exosomal miR-4745-5p/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2

2024-9-13

Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer

2024-9-13

Correction: Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA

2024-9-12

Correction: Prostate cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly

2024-9-11

Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes

2024-9-9

Advances on immunotherapy for osteosarcoma

2024-9-9

Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications

2024-9-7

Unraveling the key role of chromatin structure in cancer development through epigenetic landscape characterization of oral cancer

2024-9-6

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma

2024-9-6

NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer

2024-9-6

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

2024-9-6

Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance

2024-9-6

The prognostic effect of infiltrating immune cells is shaped by proximal M2 macrophages in lung adenocarcinoma

2024-9-4

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy

2024-9-2

Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets

2024-9-2

LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer

2024-9-2

Cellular senescence and SASP in tumor progression and therapeutic opportunities

2024-8-31

Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma

2024-8-31

Targeting m7G-enriched circKDM1A prevents colorectal cancer progression

2024-8-30

Writers, readers, and erasers RNA modifications and drug resistance in cancer

2024-8-30

Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance

2024-8-27

Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancer

2024-8-27

Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy

2024-8-26

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients

2024-8-23

The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor’s biology and their translational prospects

2024-8-22

Integration of multiomics features for blood-based early detection of colorectal cancer

2024-8-22

Circular RNAs in tumor immunity and immunotherapy

2024-8-21

Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer

2024-8-20

Exosomal miRNAs: the tumor's trojan horse in selective metastasis

2024-8-20

The role of microRNAs in the gastric cancer tumor microenvironment

2024-8-20

Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1highCD206+ pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis

2024-8-20

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

2024-8-14

Novel humanized monoclonal antibodies against ROR1 for cancer therapy

2024-8-13

Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions

2024-8-10

A case of response to combination treatment with TSA-DC-CTL immunotherapy and osimertinib in EGFR mutated advanced lung adenocarcinoma

2024-8-9

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study

2024-8-9

Refining the diagnostic utility of OLFM4 in gastric cancer precursors: a call for rigorous methodologies

2024-8-8

Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers

2024-8-7

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

2024-8-6

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

2024-8-5

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

2024-8-2

Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy

2024-8-2

Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts

2024-8-2

Cancer, metastasis, and the epigenome

2024-8-2

Super-enhancer omics in stem cell

2024-8-1

Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation

2024-7-31

Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer

2024-7-31